Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

API compliance – safeguarding the supply chain

In the war against fake medicines, protecting the upstream supply chain will be a decisive battle. Dr Gareth Evans reports on how the Council of the European Union's initial formal adoption of the Directive on Falsified Medicines in May 2011 will effect - and hopefully protect - the supply chain for active pharmaceutical ingredients (APIs).

Go Top